Insight Molecular Diagnostics, Inc. (IMDX)

5.01 +0.05 (+1.01%) USD  |  NASDAQ  |  May 08, 16:00
5.25 +0.24 (+4.79%) Pre-Market: 20:00
More

Insight Molecular Diagnostics Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for IMDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Veracyte, Inc. Upgrade
Exagen, Inc. Upgrade
bioAffinity Technologies, Inc. Upgrade
GRAIL, Inc. Upgrade
FONAR Corp. Upgrade